Founded in 2017 and based in Melbourne, Seer Medical builds patient-centric home EEG solutions that combine cloud, web, and AI technologies. Its flagship product, Seer Home, enables long-term home-based video electroencephalography (EEG) monitoring to accelerate epilepsy detection without hospitalization. The company focuses on improving access to epilepsy diagnostics for patients and clinicians through remote monitoring and data-driven workflows. Seer Medical’s technology is positioned to integrate with larger clinical EEG portfolios and support ambulatory and hospital-based diagnostic centers. Recent investment activity is intended to expand technical capacity and help bring new products to market via partnerships with strategic investors. The articles do not disclose revenue, user, or valuation metrics. Seer is a medtech diagnostics company focused on epilepsy. It was founded in 2017 by Dean Freestone, George Kenley and Mark Cook. The company has raised $34 million from investors including Cochlear, multi‑family office EWM Group, SG Hiscock and impact investor Giant Leap. Cochlear is reported to have bought into the company. The article describes Seer as cashed up and ready to expand. The piece does not disclose operating metrics or the specific financing instruments.

Total raised

$34M

Funding rounds

2

Latest round

Equity

Latest activity

Aug 2021